XLS — Xlife Sciences AG Share News
0.000.00%
- CH₣54.22m
- CH₣194.54m
- CH₣0.28m
Brief: Xlife Sciences AG Says Transaction With Veraxa, Offers Potential For A Significant Partial Exit Of Company's Investment
Veraxa Biotech to merge with SPAC Voyager in $1.64 billion deal (updated)
Veraxa Biotech to merge with SPAC Voyager in $1.64 billion deal
Brief: Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp.
Investors To Enter Stock,Plans Dual Listing On The London Stock Exchange Group
Brief: DoH - Abu Dhabi Expands Partnerships To Support Development Of Life Sciences Sector - Statement
Brief: Xlife Sciences: Pleasing Progress In First Half Of 2022
Brief: Xlife Sciences: FUSE-AI Supports German Pharmacies In Digitization